Vigonvita Life Sciences: Erectile Dysfunction trials

The registry lists 10 Erectile Dysfunction studies with Vigonvita Life Sciences as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 6Phase 2 2Phase 3 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Long-term Safety of TPN171H Tablet in Erectile Dysfunction.CompletedNCT06301854Phase 3
• Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly SubjectsCompletedNCT06090136Phase 1
• Drug-Drug Interaction (DDI) Study for TPN171HCompletedNCT06090123Phase 1
• Effect of TPN171H on SpermatogenesisCompletedNCT05585931Phase 1
• Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile DysfunctionCompletedNCT05388825Phase 2
• A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male SubjectsCompletedNCT05316428Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy SubjectsCompletedNCT05208814Phase 1
• Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.CompletedNCT05188989Phase 3
• Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver FunctionCompletedNCT05185011Phase 1
• Efficacy and Safety of TPN171H in the Patients With Erectile DysfunctionCompletedNCT04479917Phase 2